¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"end dilution value"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • free end saddle partial denture
    À¯¸®´Ü±¹¼ÒÀÇÄ¡
  • Krause¡¯s end bulb
    Å©¶ó¿ìÁ¦³¡¸Á¿ï
  • motor end organ
    ¿îµ¿Á¾¸»±â°ü
  • positive end expiratory pressure
    ³¯¼û³¡¾ç¾Ð, È£±â¸»¾ç¾Ð
  • zero end-expiratory pressure
    ³¯¼û³¡¿µÁ¡¾Ð, È£±â¸»¿µÁ¡¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • end-organ deafness
    Á¾¸»±â°ü³­Ã»
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡
  • end
    ³¡
  • end-brush
    Ãà»è³¡°¡Áö
  • end-bud
    ²¿¸®½Ï
  • end-foot
    (¢¡bouton terminal) Á¾¸»´ÜÃß
  • end-pressure
    Á¾¾Ð, Á¾¸»¾Ð
  • end group
    ¸»´Ü±â
  • end organ
    Á¾¸»±â°ü
  • end product
    ÃÖÁ¾»ê¹°
  • end group spine
    ±ê³¡°¡½Ã
  • end plate potential
    Á¾ÆÇÀüÀ§, Á¾¸»ÆÇÀüÀ§
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-point nystagmus
    ±ØÀ§´«¶³¸², ±ØÀ§¾ÈÁø
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • serial dilution protamine sulfate test
    °è´ÜÈñ¼® ÇÁ·ÎŸ¹Î¼³ÆäÀÌÆ®½ÃÇè
  • urinary dilution
    ¿äÈñ¼®(èñýüà·).
  • acid value
    »ê°ª, »ê°¡(߫ʤ).
  • average value
    Æò±ÕÄ¡.
  • base value
    ±âÁذª, ±â¼±°ª.
  • biological value
    »ý¹°ÇÐÀû °¡Ä¡(ÊÙ˧̬).
  • biological value
    »ý¹°°¡(¡­Ê¤).
  • biological value
    »ý¹°ÇÐÀû °¡Ä¡(¡­Ê¤ö·).
  • blood gas value
    Ç÷¾×°¡½º°ª(Ä¡)
  • boundary value
    °æ°èÄ¡(˭˭̬).
  • correction value
    º¸Á¤Ä¡(ËÓËøÌ¬).
  • cross over value
    ±³Â÷°ª.
  • effective value
    ½ÇÈ¿°ª, À¯È¿°ª.
  • ester value
    ¿¡½ºÅͰª.
  • exceptional value
    ¿¹¿ÜÄ¡(ËçËí̬).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • g value
    g °ª
  • G value
    G °ª
  • half-value dose
    ¹Ý(Úâ)°ª ¼±·®(àÊÕá)
  • half-value layer
    ¹Ý°¨Ãþ(ÚâÊõöµ)
  • hydroxyl value
    ÇÏÀ̵å·Ï½Ç°ª
  • Kirschner value
    Ű½´³Ê°ª
  • probability value
    È®·ü(ü¬×Ë) °ª
  • protein value
    ´Ü¹éÁú(Ó±ÛÜòõ)°ª
  • p value
    p °ª
  • p50 value
    p50 °ª
  • Q value
    Q
  • recombination value
    ÀçÁ¶ÇÕ(î¢ðÚùê) °ª
  • Rf value
    Rf°ª
  • Rg value
    Rg °ª
  • Rm value
    Rm °ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ID-MS isotope dilution-mass spectrometry
LDF laser Doppler flux, laser Doppler fluxometry; limit dilution factor
MDS Master of Dental Surgery; maternal deprivation syndrome; medical data screening; medical data system...
MHD maintenance hemodialysis; mean hemolytic dose; mental health department; minimum hemolytic dilution;...
MID maximum inhibiting dilution; mesioincisodistal; midinfarct dementia; minimum infective dose; minimum...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PV Peroxide value
PPV Positive Predictive Value
RV reference value
RVU Relative Value Units
RBV Relative biological value
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
economic value of life The evaluation of the monetary value of a life lost or a life saved.
(12 Dec 1998)
law of initial value The direction of response of a body function to any agent depends to a large degree on the initial level of that function.
Synonym: law of initial value.
(05 Mar 2000)
lower heating value (LHV) The potential energy in a fuel if the water vapour from combustion of hydrogen is not condensed.
(05 Dec 1998)
acromial end of clavicle The flattened lateral end of the clavicle that articulates with the acromion and is anchored to the coracoid process by the conoid and trapezoid ligaments.
Synonym: extremitas acromialis claviculae, acromial end of clavicle.
(05 Mar 2000)
blunt-end Refers to double-stranded DNA in which there are no unpaired bases at the end.
(05 Mar 2000)
blunt-end DNA <molecular biology> A fragment of a DNA molecule in which the ends of both strands are even with each other rather than one strand being longer than the other.
(09 Oct 1997)
blunt-end ligation A lab technique to join together two pieces of blunt-end DNA, such as an insert into a cloning vector, which requires the enzyme ligase because there are no single-stranded overhanging ends for the attachment to form more spontaneously, by itself.
(09 Oct 1997)
by-end Private end or interest; secret purpose; selfish advantage.
Alternative forms: bye-end.
(20 Mar 1998)
capped 5'-end A methylated (has a -CH3 attached) guanosine nucleotide attached to the 5'-end (the beginning) of an eukaryotic mRNA, thought to give the mRNA stability.
(09 Oct 1997)
glycosylation end products, advanced Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus.
(12 Dec 1998)
root end cyst An inflammatory odontogenic cyst derived histogenetically from Malassez' epithelial rests surrounding the root apex of a nonvital tooth.
Synonym: periapical cyst, radicular cyst, root end cyst.
(05 Mar 2000)
root end granuloma Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.
(12 Dec 1998)
miniature end plate potential <physiology> Small fluctuations (typically 0.5 mV) in the resting potential of postsynaptic cells.
They are the same shape as, but much smaller than, the end plate potentials caused by stimulation of the presynaptic cell. Miniature end plate potentials are considered as evidence for the quantal release of neurotransmitters at chemical synapses, a single miniature end plate potential resulting from the release of the contents of a single synaptic vesicle.
(12 Jan 1998)
positive end-expiratory pressure A technique used in respiratory therapy in which airway pressure greater than atmospheric pressure is achieved at the end of exhalation by introduction of a mechanical impedance to exhalation.
(05 Mar 2000)
skin test end-point titration A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • end matter
    (ÀÎ)Ã¥ÀÇ ºÎ·Ï(ÁÖ¼®,Âü°í ¹®Çå ¸ñ·Ï,»öÀÎ µî)
  • end organ
    (»ý¸®)(½Å°æÀÇ)Á¾¸» ±â°ü;´Ü¸»±â
  • end point
    Á¾·áÁ¡;Á¾Á¡;(È­)(ÀûÁ¤ÀÇ)Á¾Á¡;=ENDPOINT
  • end product
    ¿¬¼Ó º¯È­ÀÇ ÃÖÁ¾°á°ú;ÃÖÁ¾ »ý¼º¹°
  • end rhyme
    (¿î)°¢¿î
  • end run
    ¿£µå·±(°øÀ» °¡Áø ¼±¼ö°¡ ¾Æ±º ¹æ¾îÁøÀÇ Ãø¸éÀ» µ¹¾Æ ÈĹæÀ¸·Î ³ª°¡´Â Ç÷¹ÀÌ)±³¹¦ÇÑ È¸ÇÇ
  • end stop
    ¹®¹Ì ±âÈ£
  • end table
    (¼ÒÆÄ,ÀÇÀÚ °ç¿¡ ³õ´Â)ÀÛÀº Å×À̺í
  • end use
    ÃÖÁ¾ ¿ëµµ
  • end user
    ÃÖÁ¾ ¼ö¿äÀÚ;½Ç¼ö¿äÀÚ
  • end ways
    ³¡À» À§·ÎÇϰí;¼¼·Î
  • end zone
    ¿£µå Á¸(°ñ¶óÀΰú ¿£µå¶óÀÎ »çÀÌÀÇ ±¸¿ª)
  • end-
    (¿¬°áÇü)(³»ºÎ,Èí¼ö)ÀÇ ¶æ
  • fag end
    µµ·Á³½ ³¡ Á¶°¢;¸»´Ü;³²Àº Çã¼·¾²·¹±â;´ã¹è;Åä²ø;»õ³¢ÀÇ ²¿Áö ¾ÊÀº ²ôÆ®·¯¹Ì
  • front end
    ÇÁ·ÐÆ® ¿£µå(ÁõÆø,Áß°£ Á֯ļö º¯È¯ºÎ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á